Iron-Chelated Semiconducting Oligomer Nanoparticles for NIR-II Fluorescence Imaging-Guided Enhanced Chemodynamic/Photothermal Combination Therapy

Shanchao Diao,Wenheng Shi,Yaxin Liu,Tingting Liang,Zhiwei Xu,Wen Zhou,Chen Xie,Quli Fan

DOI: https://doi.org/10.1039/d3tb01305g

IF: 7.571

2023-09-02

Journal of Materials Chemistry B

Abstract:Chemodynamic therapy (CDT) has attracted increasing attention owing to its high tumor specificity and low side effect. However, the low absolute concentration of reactive oxygen species (ROS) within tumor cells restricts the CDT efficacy. Herein, we use dihydroartemisinin (DHA) to enhance the CDT efficacy and combine photothermal therapy (PTT) to further improve the anticancer effect. To achieve such goal, an iron-containing semiconducting oligomer nanoparticle (DHA@FePSOD) is prepared by loading DHA into an Fe3+-chelated NIR-II fluorescent semiconducting oligomer (FePSOD). The Fe3+ ion within DHA@FePSOD can be reduced into Fe2+ ion by glutathione (GSH) and subsequently catalyze hydrogen peroxide (H2O2) into highly toxic hydroxyl radical (·OH) for CDT. The loaded DHA may be further reduced by Fe2+ and generate DHA radical to enhance the CDT efficacy. In addition, DHA@FePSOD shows good photothermal effect and intense NIR-II fluorescence signal under 808 nm laser irradiation. Both in vitro and in vivo studies prove the better anticancer effect of DHA@FePSOD than FePSOD, which is attributed to the loaded DHA. Furthermore, DHA@FePSOD can effectively accumulate into tumor and delineate the tumor via NIR-II fluorescence imaging. This study thus provides an efficient approach for developing NIR-II fluorescence imaging-guided enhanced chemodynamic/photothermal combination therapeutic nanoplatform.

materials science, biomaterials